Shares of Skechers (SKX) were lower Wednesday after Morgan Stanley downgraded its rating on the stock to Equal-Weight from Overweight. The firm also cut its price target on the shares to $25 from $41. Analysts with Morgan Stanley believe the consumer shift toward pure fashion styles and away from athletic footwear is causing the footwear company to alter its variety, which is resulting in slower sales growth. The analysts see no positive fashion catalysts until the first half of 2017 and expect consensus estimates to decline.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.